WEE1 and cancer: Here, following evaluation of an underlying mechanism and in vivo validation of enhanced sensitivity to NK killing following WEE1 kinase inhibition with our murine model, we demonstrated that AZD1775 sensitized human cancer cells to both direct and ADCC-mediated killing.